| Date post: | 10-Apr-2019 |
| Category: |
Documents |
| Upload: | trinhkhanh |
| View: | 219 times |
| Download: | 0 times |
Page 0
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Tumors and
Malformations Perinatal Management
Christopher Cassady MD
Edward B. Singleton Department of Pediatric Radiology Texas Children’s Hospital
Page 1
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
We will discuss both
•Diagnostic Options
•Therapeutic Options
Page 2
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Diagnostic Options
Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA KAPOSIFORM HEMANGIOENDOTHELIOMA* TUFTED ANGIOMA*
Congenital Vascular Malformations AVM/AVF LYMPHATIC MALFORMATION VENOUS MALFORMATION VENOCAPILLARY MALFORMATION
Page 3
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Diagnostic Options
Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA KAPOSIFORM HEMANGIOENDOTHELIOMA*
Congenital Vascular Malformations AVM/AVF LYMPHATIC MALFORMATION
These are the diagnostic options for an imager in the perinatal period
Page 4
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
Why treat? Location: airway, compartment syndrome Shunting/heart failure Shunting/venous hypertension/ischemia Consumptive coagulopathy Hypothyroidism Cosmetic, including ulceration/bleeding
Page 5
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
Medical therapy Steroids Beta blockers Antiangiogenics Chemotherapy Endovascular therapy (embolization)/sclerotherapy Surgery Tincture of Time
Page 6
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Diagnostic Options
Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA KAPOSIFORM HEMANGIOENDOTHELIOMA*
Page 7
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
Glut 1 negative
•RICH: present at birth, involutes by 12-14 months of age •NICH: present at birth, no regression
Glut 1 positive
•Common Infantile: appears in infancy, proliferative/degenerative •Benign Neonatal Hemangiomatosis •Disseminated NH •PHACES
HEMANGIOMA
Page 8
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
HEMANGIOMA
Glut 1 negative CONSERVATIVE Treat ulcerations with local wound care STEROIDS if high output symptoms: EMBOLIZE or EXCISE
Glut 1 positive CONSERVATIVE PROPRANOLOL STEROIDS THYROXINE as necessary surgery, laser, cryoablation, chemotherapy if desperate
Page 9
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
CONGENITAL HEMANGIOMA
Page 10
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
CONGENITAL HEMANGIOMA
Page 11
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LIVER LESIONS
Lesions can be called solitary hemangioma, diffuse hemangiomatosis, hemangioendothelioma, or hepatic vascular malformation with capillary proliferation.
CONFUSING
Page 12
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LIVER LESIONS
BOSTON group: •Focal
•Behaves like a RI Congenital Hemangioma (Glut 1 -) •Usually asymptomatic; monitor for shunting
•Multifocal or Diffuse •Glut 1 +, behave like Infantile Hemangioma
•Multifocal: AV or PV shunting *HO Failure* •Diffuse: Abd Compartment Syndrome, hypothyroid
*LO Failure*
Page 13
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
FOCAL HEMANGIOMA
Page 14
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
FOCAL HEMANGIOMA
Page 15
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
FOCAL HEMANGIOMA
Page 16
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
FOCAL HEMANGIOMA
Page 17
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
DIFFUSE HEMANGIOMA
Page 18
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
Algorithm from Boston
Page 19
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
CONGENITAL HEMANGIOMA
Page 20
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
KAPOSIFORM HEMANGIOENDOTHELIOMA
Page 21
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
KAPOSIFORM HEMANGIOENDOTHELIOMA
Page 22
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
KAPOSIFORM HEMANGIOENDOTHELIOMA
•Systemic corticosteroids
•Alpha interferon
•AntiAngiogenics
•Multimodal intervention
•Surgery: not generally first-line because of infiltration
Page 23
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Diagnostic Options
Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA KAPOSIFORM HEMANGIOENDOTHELIOMA*
Congenital Vascular Malformations AVM/AVF LYMPHATIC MALFORMATION
Page 24
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
AVM/AVF
Page 25
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
AVM/AVF
Page 26
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
PORTOSYSTEMIC FISTULA
Congenital arterioportal fistulae •Present as neonates with FTT and abdominal distension from splenomegaly, +/- GI bleeding •enlarged hepatic artery with dilation of the PV at the fistula, pulsatile hepatofugal flow in PV •Treated angiographically with coil/particle embolization
Page 27
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LIVER LESIONS
Page 28
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LIVER LESIONS
Page 29
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
Patent Ductus Venosus
Page 30
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
Patent Ductus Venosus
Page 31
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LYMPHATIC MALFORMATIONS
Lesions that require treatment for location typically get a combination of •Surgery (debulking)
•Intralesional sclerotherapy with
•Doxycycline •Bleomycin •OK432 •STS+ (EtOH or doxycycline)
Page 32
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LYMPHATIC MALFORMATIONS
Page 33
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LYMPHATIC MALFORMATIONS
Page 34
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LYMPHATIC MALFORMATIONS
Page 35
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LYMPHATIC MALFORMATIONS
Page 36
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Therapeutic Options
LYMPHATIC MALFORMATIONS
Page 37
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
Diagnostic with Therapeutic Options
Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA Glut 1 - : Nothing, or steroids Glut 1+ : Nothing, or propranolol KAPOSIFORM HEMANGIOENDOTHELIOMA Steroids, Multimodality therapy
Congenital Vascular Malformations AVM/AVF Endovascular therapy LYMPHATIC MALFORMATION Sclerotherapy +/- surgery
Page 38
xxx00.#####.ppt 12/4/2012 3:05:55 PM
Vascular Lesion Management
SELECTED REFERENCES
Christison-Lagay, ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, Paltiel HJ, Klement J, Mulliken JB, Fishman SJ. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Ped Surg 2007; 42: 62-68.
Solomon T, Ninnis J, Deming D, Merritt TA, Hopper A. Use of propranolol for treatment of hemangiomas in PHACE syndrome. J Perinatol 2011 Nov;31(11):739-41
Lawley LP, Siegfried E, Todd JL.. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009 Sep-Oct;26(5):610-4.
Teplisky D, Tincani EU, Lipsich J, Sierre S. Congenital arteriportal fistulas: radiologic treatment and color Doppler US follow up. Pediatrr Radiol 2012 Nov ;42(11): 1326-1332.
